Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Pageof 10